Therapeutic Benefits by Human Mesenchymal Stem Cells (hMSCs) and Ang-1 Gene-Modified hMSCs after Cerebral Ischemia
Top Cited Papers
Open Access
- 18 July 2007
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 28 (2), 329-340
- https://doi.org/10.1038/sj.jcbfm.9600527
Abstract
Transplantation of human mesenchymal stem cells (hMSCs) prepared from adult bone marrow has been reported to ameliorate functional deficits after cerebral artery occlusion in rats. Although several...Keywords
This publication has 43 references indexed in Scilit:
- Demyelinating diseases and potential repair strategiesInternational Journal of Developmental Neuroscience, 2007
- Mesenchymal Stem Cells Derived from Peripheral Blood Protects against IschemiaJournal of Neurotrauma, 2007
- Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cellsBrain Research, 2006
- Intravenous administration of glial cell line‐derived neurotrophic factor gene‐modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult ratJournal of Neuroscience Research, 2006
- Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemiaBrain, 2006
- Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosisNature, 2003
- Serial MRI After Transient Focal Cerebral Ischemia in RatsStroke, 2000
- Role of angiogenesis in patients with cerebral ischemic stroke.Stroke, 1994
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.Stroke, 1986